Safety and Performance of the SpineVision Posterior Fixation Systems in Thoracolumbar Spinal Treatment

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

330 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-09-22

Study Completion Date

2028-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to confirm the safety and performance of the three (3) Spinevision posterior fixations systems Lumis®, Plus® and Ulis® , in the treatment of patient suffering from thoracolumbar spinal degenerative pathologies, or degenerative disc disease (disease that occurs when the spinal disk break down) associated pathologies.

Part of their standard of care, participants will be questioned on their back and leg pains, their disability and if they have encountered any adverse effects since the Spinevision posterior fixation system implant surgery. Those data will be collected up to twenty four (24) months after the Spinevision posterior fixation system implant surgery.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Pivotal Study of the Premia Spine TOPS™ System

NCT03012776

Lumbar Spinal Stenosis Degenerative Spondylolisthesis

COMPLETED NA

Titanium Surgical Mesh and MOSS-Miami Screws for Lumbar Fusion.

NCT00215319

Degenerative Disc Disease

COMPLETED PHASE3

Safety and Preliminary Effectiveness of NVD-001 for the Treatment of Low Grade Degenerative Lumbar Spondylolisthesis

NCT03100032

Spondylolisthesis

COMPLETED PHASE1/PHASE2

Safety and Performance of the SPINEVISION Hexanium ACIF in the Treatment of Cervical Spine Degenerative Disc Disease

NCT06155409

Intervertebral Disc Degeneration

ACTIVE_NOT_RECRUITING

A Retrospective Review of Early Onset Spinal Deformity Patients Treated With the Ellipse MAGEC System

NCT01716936

Thoracic Insufficiency Syndrome

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Fixed D3 study is a multicentric, non-randomized, ambispective, post market clinical follow-up study. This means that either subjects already implanted with one (1) of the Spinevision posterior fixations systems (Lumis, Plus or Ulis) - retrospective subjects - or subjects planned for treatment with one of the Spinevision posterior fixation system (prospective subjects) can be enrolled in the study.

Standard of care data up to twenty four (24) months post Spinevision posterior fixation system implant procedure will be collected; key data include back and leg Visual Analogue Score (VAS) pain, Oswestry Disability Index (ODI) score, and adverse events.

Data will be collected at pre-operative, per-operative, and post-operative Month 2, Month 6, Month 12 and Month 24.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intervertebral Disc Degeneration

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pedicle fixation surgery

Pedicle fixation surgery indicates a surgical approach in the thoracic spine down to sacral spine to either support interbody fusion (fusion of the discal space between two vertebrae) , or to correct spinal deformity.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient implanted with Lumis®, Plus® or Ulis® posterior fixation system
* Patient of 18 years old and more
* Patient has provided signed informed consent or did not oppose to his/her data collection, per local regulation

Exclusion Criteria

* trauma (i.e., fracture or dislocation)
* Known or suspected allergy or intolerance to the implanted material, mainly to metal (e.g., cobalt, chromium, nickel, etc.)
* Any other medical or surgical condition likely to compromise the success of instrumented surgery, such as the presence of a malignant tumor or serious congenital abnormalities, raised erythrocyte sedimentation rate not explained by other diseases, high white blood cell count or a tendency to low white blood cell count
* All cases not described in the indications
* Localized infection of the operative site
* All patients with insufficient tissue cover of the operative site
* Local signs of inflammation
* Fever or leukocytosis
* Pathological obesity
* Pregnancy
* Mental illness
* Rapidly evolving joint diseases, bone absorption, osteopenia and/or osteoporosis. Osteoporosis is a relative contraindication, as this medical condition can limit the expected correction gain and stability of mechanical fixation
* All cases not requiring bone graft or bone fusion
* When pedicular screws are used, absence or malformation of pedicles
* All cases requiring a combination of different metals
* All patients not agreeing to comply with post-operative instructions

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No